| Coagulation and cancer: biological and clinical aspects A Falanga, M Marchetti, A Vignoli Journal of Thrombosis and Haemostasis 11 (2), 223-233, 2013 | 560 | 2013 |
| Polymorphonuclear leukocyte activation and hemostasis in patients with essential thrombocythemia and polycythemia vera A Falanga, M Marchetti, V Evangelista, A Vignoli, M Licini, M Balicco, ... Blood, The Journal of the American Society of Hematology 96 (13), 4261-4266, 2000 | 372 | 2000 |
| Leukocyte-platelet interaction in patients with essential thrombocythemia and polycythemia vera A Falanga, M Marchetti, A Vignoli, D Balducci, T Barbui Experimental hematology 33 (5), 523-530, 2005 | 292 | 2005 |
| Mechanisms and risk factors of thrombosis in cancer A Falanga, L Russo, V Milesi, A Vignoli Critical reviews in oncology/hematology 118, 79-83, 2017 | 260 | 2017 |
| V617F JAK-2 mutation in patients with essential thrombocythemia: relation to platelet, granulocyte, and plasma hemostatic and inflammatory molecules A Falanga, M Marchetti, A Vignoli, D Balducci, L Russo, V Guerini, ... Experimental hematology 35 (5), 702-711, 2007 | 239 | 2007 |
| Clotting mechanisms and cancer: implications in thrombus formation and tumor progression. A Falanga, M Marchetti, A Vignoli, D Balducci Clinical advances in hematology & oncology: H&O 1 (11), 673-678, 2003 | 151 | 2003 |
| Defibrotide reduces procoagulant activity and increases fibrinolytic properties of endothelial cells A Falanga, A Vignoli, M Marchetti, T Barbui Leukemia 17 (8), 1636-1642, 2003 | 144 | 2003 |
| Endothelial capillary tube formation and cell proliferation induced by tumor cells are affected by low molecular weight heparins and unfractionated heparin M Marchetti, A Vignoli, L Russo, D Balducci, M Pagnoncelli, T Barbui, ... Thrombosis research 121 (5), 637-645, 2008 | 111 | 2008 |
| Nitric oxide derivatives and soluble plasma selectins in patients with myeloproliferative neoplasms G Cella, M Marchetti, F Vianello, M Panova-Noeva, A Vignoli, L Russo, ... Thrombosis and haemostasis 104 (07), 151-156, 2010 | 84 | 2010 |
| Differential effect of the low-molecular-weight heparin, dalteparin, and unfractionated heparin on microvascular endothelial cell hemostatic properties A Vignoli, M Marchetti, D Balducci, T Barbui, A Falanga Haematologica 91 (2), 207-214, 2006 | 69 | 2006 |
| LMWH bemiparin and ULMWH RO-14 reduce the endothelial angiogenic features elicited by leukemia, lung cancer, or breast cancer cells A Vignoli, M Marchetti, L Russo, E Cantalino, E Diani, G Bonacina, ... Cancer investigation 29 (2), 153-161, 2011 | 59 | 2011 |
| All-trans retinoic acid modulates microvascular endothelial cell hemostatic properties M Marchetti, A Vignoli, MR Bani, D Balducci, T Barbui, A Falanga Haematologica 88 (8), 895-905, 2003 | 43 | 2003 |
| Hypercoagulation screening as an innovative tool for risk assessment, early diagnosis and prognosis in cancer: the HYPERCAN study A Falanga, A Santoro, R Labianca, F De Braud, G Gasparini, A D’Alessio, ... Thrombosis Research 140, S55-S59, 2016 | 35 | 2016 |
| Thrombotic biomarkers for risk prediction of malignant disease recurrence in patients with early stage breast cancer C Giaccherini, M Marchetti, G Masci, C Verzeroli, L Russo, L Celio, ... Haematologica 105 (6), 1704, 2020 | 31 | 2020 |
| Pathogenesis of thrombosis in cancer A Falanga, M Marchetti, A Vignoli Thromb and cancer 30, 11-23, 2004 | 30 | 2004 |
| Multistate models: accurate and dynamic methods to improve predictions of thrombotic risk in patients with cancer A Carmona-Bayonas, P Jimenez-Fonseca, M Garrido, A Custodio, ... Thrombosis and Haemostasis 119 (11), 1849-1859, 2019 | 27 | 2019 |
| Thrombin generation predicts early recurrence in breast cancer patients M Marchetti, C Giaccherini, G Masci, C Verzeroli, L Russo, L Celio, ... Journal of Thrombosis and Haemostasis 18 (9), 2220-2231, 2020 | 24 | 2020 |
| Comparative assessment of low-molecular-weight heparins in cancer from the perspective of patient outcomes and survival A Falanga, A Vignoli, E Diani, M Marchetti Patient related outcome measures, 175-188, 2011 | 22 | 2011 |
| Blood oxidative status and selectins plasma levels in healthy donors receiving granulocyte-colony stimulating factor G Cella, M Marchetti, A Vignoli, ML Randi, G Saggiorato, L Pasetto, ... Leukemia 20 (8), 1430-1434, 2006 | 21 | 2006 |
| Venous thromboembolism in oncology. A Falanga, A Vignoli Eksperimental'naia Onkologiia 26 (1), 11-14, 2004 | 19 | 2004 |
Marina MarchettiBiologo, ASST Papa Giovanni XXIIIEmail verificata su asst-pg23.it
